Contract facts
FederalNo full NAICS 325412 intel page yet. Browse NAICS intelligence
IDIQ 36C24822D0048 - 5 task orders is a federal award for 248-Network Contract Office 8 (36C248) held by Jubilant Draximage Radiopharmacies Inc. Estimated value $1.4M ($1M obligated). Current period of performance ends Mar 14, 2027.
Department of Veterans Affairs (VA) parent IDV 36C24822D0048 rolls up 5 task orders at 248-NETWORK CONTRACT OFFICE 8 (36C248). Cluster estimated value $1.4M; obligated $1.0M. Incumbents include JUBILANT DRAXIMAGE RADIOPHARMACIES INC..
Recompete timing
PublicCurrent PoP ends Mar 14, 2027 (205 days remaining). Agencies typically plan 12–18 months ahead — at 6.7 months out, that window is already open. The buying decision is likely already in motion.
Incumbent footprint
Public recordJubilant Draximage Radiopharmacies Inc — $2.0M obligated across 33 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C24822D0048?
36C24822D0048 (IDIQ 36c24822d0048 - 5 task orders) is a 248-Network Contract Office 8 (36C248) award with an estimated value of $1.4M, currently held by Jubilant Draximage Radiopharmacies Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C248-22-D-0048?
36C248-22-D-0048 is the dashed form of PIID 36C24822D0048 (IDIQ 36c24822d0048 - 5 task orders), held by Jubilant Draximage Radiopharmacies Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C24822D0048?
248-Network Contract Office 8 (36C248) awarded 36C24822D0048 to Jubilant Draximage Radiopharmacies Inc.
Who is the incumbent on 36C24822D0048?
Jubilant Draximage Radiopharmacies Inc is the incumbent with $2.0M across 33 related awards in SCOUT’s public footprint. The current period of performance ends Mar 14, 2027.
When does Jubilant Draximage Radiopharmacies Inc’s 36C24822D0048 come up for recompete?
SCOUT tracks a period-of-performance end of Mar 14, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.